Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Todos Medical Ltd (OP:TOMDF)

0.0001 UNCHANGED
Last Price Updated: 11:20 AM EDT, Sep 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Todos Medical Ltd

< Previous 1 2 3 4 5 6 7 Next >
Billy Blanks Endorses Todos Medical's Line of Tollovid Products
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Todos Medical To Present At The Proactive One2One Virtual Forum
- Thursday, March 17, 2022 at 2:00PM – 2:30PM ET - 
Via Benzinga
Todos Medical to Present at the Proactive One2One Virtual Forum
- Thursday, March 17, 2022 at 2:00 PM – 2:30 PM ET - 
Via NewMediaWire
Todos Medical Completes Acquisition Of Key Assets And Intellectual Property From NLC Pharma
- Forms new subsidiary, 3CL Pharma, focused on the development and commercialization of 3CL protease-related products including Tollovir™, Tollovid®, Tollovid Daily™ and TolloTest™ for COVID-19 - 
Via Benzinga
Todos Medical Completes Acquisition of Key Assets and Intellectual Property from NLC Pharma
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Todos Medical To Present At The Emerging Growth Conference
- Wednesday, March 16, 2022 at 1:30 pm – 2 pm EST - 
Via Benzinga
Pepperdine University Hosts the 22nd Annual Celebrity Flag Football Challenge, Presented by Todos Medical's Tollovid
In support of First Responders, Military Service Members and Boys and Girls Youth Groups 
Via NewMediaWire
Todos Medical to Present at the Emerging Growth Conference
- Wednesday, March 16, 2022 at 1:30 pm – 2 pm EST - 
Via NewMediaWire
Todos Medical Appoints Greg Meiselbach As Vice President Of Government Affairs
New York, NY, and Tel Aviv, ISRAEL – March 8, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today... 
Via Benzinga
Todos Medical Appoints Greg Meiselbach as Vice President of Government Affairs
New York, NY, and Tel Aviv, ISRAEL - (NewMediaWire) - March 8, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, 
Via NewMediaWire
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
Photo from Jason Briscoe on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Benzinga Announces This Week's All Access Guests
Benzinga is thrilled to announce the guest lineup for our next All Access show, sponsored by TiiCKER, set to air Friday, February 11 at 9:15 am ET. The Lineup 9:15 am... 
Via Benzinga
Abbott Labs Outlook Cools the Omicron Led Testing Boom
Photo by Adam Nieścioruk on Unsplash 
Via Benzinga
Todos Medical And NLC Pharma Announce Primary And Secondary Endpoints Met In NLC-V-01 Phase 2 Clinical Trial Of Oral Antiviral 3CL Protease Inhibitor Tollovir™ In The Treatment Of Hospitalized COVID-19 Patients
Phase 2 Study NLC-V-01 closed early after interim data analysis due to positive clinical efficacy 
Via Benzinga
Todos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir(TM) in the Treatment of Hospitalized COVID-19 Patients
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
Todos Medical Announces Data Lock in Tollovir™ Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients
Clinical Data will be released Thursday, January 27th, 2022 New York, NY, and Tel Aviv, ISRAEL – January 24, 2021 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive... 
Via Benzinga
Todos Medical Announces Data Lock in Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
PEPPERDINE UNIVERSITY HOSTS THE 22ND ANNUAL CELEBRITY FLAG FOOTBALL CHALLENGE®, PRESENTED BY TODOS MEDICAL'S TOLLOVID®
In support of First Responders, Military Service Members and Boys and Girls Youth Groups MALIBU, CALIFORNIA January 19, 2022: Working along with the NFL Host Committee, Celebrity... 
Via Benzinga
Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
New York, NY, and Tel Aviv, ISRAEL - (NewMediaWire) - January 18, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today released videos of... 
Via NewMediaWire
Exposures COVID-19
Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
New York, NY, and Tel Aviv, ISRAEL – January 18, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today released... 
Via Benzinga
Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022
CEO Fox Business Interview discussing COVID testing and solutions to address the crisis now online at https://video.foxbusiness.com/v/6291325085001#sp=show-clips New York... 
Via Benzinga
Todos Medical to Announce Topline Results from Tollovir Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir™ on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022
“COVID Testing: What Needs to Happen Now to Turn the Corner in 2022” CEO blog released New York, NY, and Tel Aviv, ISRAEL – January 10, 2022 - Todos Medical,... 
Via Benzinga
Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022
“COVID Testing: What Needs to Happen Now to Turn the Corner in 2022” CEO blog released 
Via NewMediaWire
Exposures COVID-19
Todos Medical CEO Provides Letter to Shareholders
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Todos Medical to Present at January 5, 2022 Emerging Growth Conference
New York, NY, and Tel Aviv, ISRAEL – January 3, 2021 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced... 
Via Benzinga
Todos Medical to Present at January 5, 2022 Emerging Growth Conference
NEW YORK, NY and TEL AVIV, Israel - (NewMediaWire) - January 03, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Todos... 
Via NewMediaWire
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
Pfizer (NYSE: PFE) is arguably one of the biggest leaders in COVID-19 technology, whether it’s their vaccine or their newly approved oral antiviral called Paxlovid. The... 
Via Benzinga
Todos Medical Records Record Weekly COVID PCR Testing Volumes at Provista
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer's Paxlovid Approval, Tollovir™ Phase 2 & COVID Testing
CEO Gerald Commissiong is also scheduled to appear on BNC at 1:50PM EST to discuss the authorization of Pfizer’s COVID antiviral drug & Tollovir™ Phase 2 for... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.